DIABETESpredict®, a first of its kind predictive genetic test for type 2 diabetes, is now being administered to help improve patient outcomes during the COVID-19 pandemic. According to a recent study on the bidirectional relationship of type 2 diabetes and COVID-19, patients with type 2 diabetes are predisposed to adverse clinical outcomes from the COVID-19 virus. In addition, many COVID-19 patients are found to develop new onset diabetes after infection (1). DIABETESpredict® proactively determines a patient's type 2 diabetes genetic risk. It then provides physicians with individualized lifestyle and diet recommendations for the prevention and management of type 2 diabetes, helping to reduce the probability of severe infection by COVID-19 or post infection disease onset.